-transparent.png){kind=logo}
The pharmacokinetic disposition of prednisolone was studied following oral administration (10 mg) to eight patients with untreated coeliac disease of mild or moderate severity, seven coeliac patients on a strict gluten-free diet and ten normal subjects. No significant differences were shown in the peak prednisolone level, the time of the peak level, the area under the concentration versus time plot, the plasma half-life and the 24 h urinary recovery of prednisolone in the three subject groups. There was however considerable variability within each group. It is concluded that the presence of coeliac disease does not significantly alter the absorption or elimination of prednisolone.
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
January 1981,
Digestion,
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
December 1967,
Lancet (London, England),
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
November 1972,
Clinical science,
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
July 1982,
Clinical science (London, England : 1979),
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
December 1949,
Archives of disease in childhood,
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
October 1951,
Archives of disease in childhood,
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
November 1976,
British medical journal,
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
January 1977,
British medical journal,
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
June 1976,
The Journal of antimicrobial chemotherapy,
M E Pickup, and
F Farah, and
J R Lowe, and
J S Dixon, and
C O Record
February 1976,
Gut,
